nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—migraine—Prednisone—chronic obstructive pulmonary disease	0.488	1	CpDpCtD
Zolmitriptan—CYP1A2—chronic obstructive pulmonary disease	0.345	1	CbGaD
Zolmitriptan—Rizatriptan—CYP1A2—chronic obstructive pulmonary disease	0.000874	0.289	CrCbGaD
Zolmitriptan—Melatonin—MPO—chronic obstructive pulmonary disease	0.000707	0.234	CrCbGaD
Zolmitriptan—Almotriptan—CYP1A2—chronic obstructive pulmonary disease	0.000606	0.201	CrCbGaD
Zolmitriptan—Melatonin—CYP1A1—chronic obstructive pulmonary disease	0.000424	0.14	CrCbGaD
Zolmitriptan—Melatonin—CYP1A2—chronic obstructive pulmonary disease	0.000409	0.135	CrCbGaD
Zolmitriptan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00118	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00118	CcSEcCtD
Zolmitriptan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00118	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00118	CcSEcCtD
Zolmitriptan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00118	CcSEcCtD
Zolmitriptan—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00118	CcSEcCtD
Zolmitriptan—Infection—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00117	CcSEcCtD
Zolmitriptan—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00117	CcSEcCtD
Zolmitriptan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Zolmitriptan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Zolmitriptan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Zolmitriptan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Zolmitriptan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00115	CcSEcCtD
Zolmitriptan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00115	CcSEcCtD
Zolmitriptan—Infection—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00115	CcSEcCtD
Zolmitriptan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00115	CcSEcCtD
Zolmitriptan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00114	CcSEcCtD
Zolmitriptan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00114	CcSEcCtD
Zolmitriptan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.00114	CcSEcCtD
Zolmitriptan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00114	CcSEcCtD
Zolmitriptan—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00113	CcSEcCtD
Zolmitriptan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00113	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00113	CcSEcCtD
Zolmitriptan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00112	CcSEcCtD
Zolmitriptan—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00112	CcSEcCtD
Zolmitriptan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00111	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00111	CcSEcCtD
Zolmitriptan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00111	CcSEcCtD
Zolmitriptan—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.0011	CcSEcCtD
Zolmitriptan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.0011	CcSEcCtD
Zolmitriptan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00109	CcSEcCtD
Zolmitriptan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00109	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00109	CcSEcCtD
Zolmitriptan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00109	CcSEcCtD
Zolmitriptan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00108	CcSEcCtD
Zolmitriptan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00108	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00108	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00107	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00107	CcSEcCtD
Zolmitriptan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00107	CcSEcCtD
Zolmitriptan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00107	CcSEcCtD
Zolmitriptan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00106	CcSEcCtD
Zolmitriptan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00106	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00105	CcSEcCtD
Zolmitriptan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00105	CcSEcCtD
Zolmitriptan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00105	CcSEcCtD
Zolmitriptan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00105	CcSEcCtD
Zolmitriptan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00105	CcSEcCtD
Zolmitriptan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00104	CcSEcCtD
Zolmitriptan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00104	CcSEcCtD
Zolmitriptan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00104	CcSEcCtD
Zolmitriptan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00104	CcSEcCtD
Zolmitriptan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.00103	CcSEcCtD
Zolmitriptan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00103	CcSEcCtD
Zolmitriptan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.00102	CcSEcCtD
Zolmitriptan—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00102	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00102	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00102	CcSEcCtD
Zolmitriptan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00102	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00101	CcSEcCtD
Zolmitriptan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00101	CcSEcCtD
Zolmitriptan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00101	CcSEcCtD
Zolmitriptan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00101	CcSEcCtD
Zolmitriptan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00101	CcSEcCtD
Zolmitriptan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00101	CcSEcCtD
Zolmitriptan—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.001	CcSEcCtD
Zolmitriptan—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000132	0.001	CcSEcCtD
Zolmitriptan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000999	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000997	CcSEcCtD
Zolmitriptan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000992	CcSEcCtD
Zolmitriptan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000989	CcSEcCtD
Zolmitriptan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000987	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000987	CcSEcCtD
Zolmitriptan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.000985	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000981	CcSEcCtD
Zolmitriptan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000981	CcSEcCtD
Zolmitriptan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00098	CcSEcCtD
Zolmitriptan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000976	CcSEcCtD
Zolmitriptan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000975	CcSEcCtD
Zolmitriptan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000973	CcSEcCtD
Zolmitriptan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000971	CcSEcCtD
Zolmitriptan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000971	CcSEcCtD
Zolmitriptan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00097	CcSEcCtD
Zolmitriptan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000967	CcSEcCtD
Zolmitriptan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000966	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000964	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000964	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000961	CcSEcCtD
Zolmitriptan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000952	CcSEcCtD
Zolmitriptan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000952	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000944	CcSEcCtD
Zolmitriptan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000944	CcSEcCtD
Zolmitriptan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000936	CcSEcCtD
Zolmitriptan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000936	CcSEcCtD
Zolmitriptan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000932	CcSEcCtD
Zolmitriptan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000932	CcSEcCtD
Zolmitriptan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000932	CcSEcCtD
Zolmitriptan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000932	CcSEcCtD
Zolmitriptan—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000929	CcSEcCtD
Zolmitriptan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.000929	CcSEcCtD
Zolmitriptan—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000922	CcSEcCtD
Zolmitriptan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.000921	CcSEcCtD
Zolmitriptan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.00092	CcSEcCtD
Zolmitriptan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000121	0.00092	CcSEcCtD
Zolmitriptan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000917	CcSEcCtD
Zolmitriptan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000917	CcSEcCtD
Zolmitriptan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.000915	CcSEcCtD
Zolmitriptan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000915	CcSEcCtD
Zolmitriptan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000913	CcSEcCtD
Zolmitriptan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000913	CcSEcCtD
Zolmitriptan—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000911	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00091	CcSEcCtD
Zolmitriptan—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000901	CcSEcCtD
Zolmitriptan—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000894	CcSEcCtD
Zolmitriptan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000884	CcSEcCtD
Zolmitriptan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00088	CcSEcCtD
Zolmitriptan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00088	CcSEcCtD
Zolmitriptan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000868	CcSEcCtD
Zolmitriptan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000868	CcSEcCtD
Zolmitriptan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.000867	CcSEcCtD
Zolmitriptan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000851	CcSEcCtD
Zolmitriptan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000846	CcSEcCtD
Zolmitriptan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000846	CcSEcCtD
Zolmitriptan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000834	CcSEcCtD
Zolmitriptan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000834	CcSEcCtD
Zolmitriptan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000832	CcSEcCtD
Zolmitriptan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000828	CcSEcCtD
Zolmitriptan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00082	CcSEcCtD
Zolmitriptan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000817	CcSEcCtD
Zolmitriptan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000806	CcSEcCtD
Zolmitriptan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000806	CcSEcCtD
Zolmitriptan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000803	CcSEcCtD
Zolmitriptan—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000105	0.0008	CcSEcCtD
Zolmitriptan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000798	CcSEcCtD
Zolmitriptan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00079	CcSEcCtD
Zolmitriptan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000787	CcSEcCtD
Zolmitriptan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000782	CcSEcCtD
Zolmitriptan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000779	CcSEcCtD
Zolmitriptan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000779	CcSEcCtD
Zolmitriptan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000763	CcSEcCtD
Zolmitriptan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.000761	CcSEcCtD
Zolmitriptan—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.82e-05	0.000749	CcSEcCtD
Zolmitriptan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.82e-05	0.000749	CcSEcCtD
Zolmitriptan—Rash—Arformoterol—chronic obstructive pulmonary disease	9.74e-05	0.000743	CcSEcCtD
Zolmitriptan—Rash—Formoterol—chronic obstructive pulmonary disease	9.74e-05	0.000743	CcSEcCtD
Zolmitriptan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.73e-05	0.000742	CcSEcCtD
Zolmitriptan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.73e-05	0.000742	CcSEcCtD
Zolmitriptan—Weight increased—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000742	CcSEcCtD
Zolmitriptan—Headache—Formoterol—chronic obstructive pulmonary disease	9.68e-05	0.000738	CcSEcCtD
Zolmitriptan—Headache—Arformoterol—chronic obstructive pulmonary disease	9.68e-05	0.000738	CcSEcCtD
Zolmitriptan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.65e-05	0.000736	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000736	CcSEcCtD
Zolmitriptan—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.62e-05	0.000734	CcSEcCtD
Zolmitriptan—Rash—Montelukast—chronic obstructive pulmonary disease	9.54e-05	0.000728	CcSEcCtD
Zolmitriptan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.53e-05	0.000727	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000726	CcSEcCtD
Zolmitriptan—Headache—Montelukast—chronic obstructive pulmonary disease	9.48e-05	0.000723	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.4e-05	0.000717	CcSEcCtD
Zolmitriptan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.37e-05	0.000715	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000713	CcSEcCtD
Zolmitriptan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000713	CcSEcCtD
Zolmitriptan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.28e-05	0.000708	CcSEcCtD
Zolmitriptan—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.26e-05	0.00279	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.26e-05	0.00279	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.26e-05	0.00279	CbGpPWpGaD
Zolmitriptan—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.000705	CcSEcCtD
Zolmitriptan—MAOA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.22e-05	0.00278	CbGpPWpGaD
Zolmitriptan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.21e-05	0.000703	CcSEcCtD
Zolmitriptan—Rash—Salbutamol—chronic obstructive pulmonary disease	9.2e-05	0.000702	CcSEcCtD
Zolmitriptan—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.2e-05	0.000701	CcSEcCtD
Zolmitriptan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.19e-05	0.000701	CcSEcCtD
Zolmitriptan—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.18e-05	0.0007	CcSEcCtD
Zolmitriptan—Nausea—Formoterol—chronic obstructive pulmonary disease	9.18e-05	0.0007	CcSEcCtD
Zolmitriptan—Headache—Salbutamol—chronic obstructive pulmonary disease	9.14e-05	0.000697	CcSEcCtD
Zolmitriptan—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.12e-05	0.00275	CbGpPWpGaD
Zolmitriptan—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.02e-05	0.00272	CbGpPWpGaD
Zolmitriptan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.01e-05	0.000687	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9e-05	0.00271	CbGpPWpGaD
Zolmitriptan—Nausea—Montelukast—chronic obstructive pulmonary disease	8.99e-05	0.000686	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.94e-05	0.00269	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.9e-05	0.00268	CbGpPWpGaD
Zolmitriptan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.88e-05	0.000678	CcSEcCtD
Zolmitriptan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.85e-05	0.000675	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	8.82e-05	0.00266	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.77e-05	0.00264	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.76e-05	0.00264	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.75e-05	0.00264	CbGpPWpGaD
Zolmitriptan—MAOA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.74e-05	0.00263	CbGpPWpGaD
Zolmitriptan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000665	CcSEcCtD
Zolmitriptan—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.67e-05	0.000661	CcSEcCtD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.66e-05	0.00261	CbGpPWpGaD
Zolmitriptan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.62e-05	0.000658	CcSEcCtD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.6e-05	0.00259	CbGpPWpGaD
Zolmitriptan—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.52e-05	0.00065	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.47e-05	0.00255	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.42e-05	0.00254	CbGpPWpGaD
Zolmitriptan—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000642	CcSEcCtD
Zolmitriptan—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.000638	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.000638	CcSEcCtD
Zolmitriptan—Shock—Prednisolone—chronic obstructive pulmonary disease	8.23e-05	0.000628	CcSEcCtD
Zolmitriptan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.17e-05	0.000623	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.09e-05	0.000617	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.9e-05	0.00238	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.84e-05	0.00236	CbGpPWpGaD
Zolmitriptan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000592	CcSEcCtD
Zolmitriptan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.00059	CcSEcCtD
Zolmitriptan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000583	CcSEcCtD
Zolmitriptan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000577	CcSEcCtD
Zolmitriptan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.000573	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.5e-05	0.00226	CbGpPWpGaD
Zolmitriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.48e-05	0.00225	CbGpPWpGaD
Zolmitriptan—Erythema—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000568	CcSEcCtD
Zolmitriptan—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.38e-05	0.00222	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.37e-05	0.00222	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.32e-05	0.00221	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.21e-05	0.00217	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.18e-05	0.00216	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.17e-05	0.00216	CbGpPWpGaD
Zolmitriptan—Pain—Prednisolone—chronic obstructive pulmonary disease	7.16e-05	0.000546	CcSEcCtD
Zolmitriptan—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	7.03e-05	0.00212	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7e-05	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.94e-05	0.00209	CbGpPWpGaD
Zolmitriptan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000527	CcSEcCtD
Zolmitriptan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.9e-05	0.000526	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.86e-05	0.00207	CbGpPWpGaD
Zolmitriptan—Agitation—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000522	CcSEcCtD
Zolmitriptan—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000519	CcSEcCtD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.72e-05	0.00202	CbGpPWpGaD
Zolmitriptan—Malaise—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000512	CcSEcCtD
Zolmitriptan—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.69e-05	0.000511	CcSEcCtD
Zolmitriptan—Syncope—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.00051	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.67e-05	0.00201	CbGpPWpGaD
Zolmitriptan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.65e-05	0.000507	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.58e-05	0.00198	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.58e-05	0.00198	CbGpPWpGaD
Zolmitriptan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000499	CcSEcCtD
Zolmitriptan—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000492	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.44e-05	0.00194	CbGpPWpGaD
Zolmitriptan—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.43e-05	0.000491	CcSEcCtD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.41e-05	0.00193	CbGpPWpGaD
Zolmitriptan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000484	CcSEcCtD
Zolmitriptan—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000484	CcSEcCtD
Zolmitriptan—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.32e-05	0.0019	CbGpPWpGaD
Zolmitriptan—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000482	CcSEcCtD
Zolmitriptan—HTR1D—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.27e-05	0.00189	CbGpPWpGaD
Zolmitriptan—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000478	CcSEcCtD
Zolmitriptan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.17e-05	0.00047	CcSEcCtD
Zolmitriptan—HTR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.14e-05	0.00185	CbGpPWpGaD
Zolmitriptan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000464	CcSEcCtD
Zolmitriptan—Oedema—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000464	CcSEcCtD
Zolmitriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.07e-05	0.00183	CbGpPWpGaD
Zolmitriptan—Infection—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000461	CcSEcCtD
Zolmitriptan—Shock—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000456	CcSEcCtD
Zolmitriptan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000455	CcSEcCtD
Zolmitriptan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000453	CcSEcCtD
Zolmitriptan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.91e-05	0.000451	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000448	CcSEcCtD
Zolmitriptan—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.81e-05	0.00175	CbGpPWpGaD
Zolmitriptan—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000442	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.76e-05	0.00173	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.69e-05	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.64e-05	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.61e-05	0.00169	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.57e-05	0.00168	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.56e-05	0.00168	CbGpPWpGaD
Zolmitriptan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000423	CcSEcCtD
Zolmitriptan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000422	CcSEcCtD
Zolmitriptan—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.00042	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.49e-05	0.00165	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.49e-05	0.00165	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.46e-05	0.00165	CbGpPWpGaD
Zolmitriptan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000416	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.45e-05	0.00164	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000408	CcSEcCtD
Zolmitriptan—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.34e-05	0.00161	CbGpPWpGaD
Zolmitriptan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000403	CcSEcCtD
Zolmitriptan—Rash—Prednisolone—chronic obstructive pulmonary disease	5.28e-05	0.000402	CcSEcCtD
Zolmitriptan—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.28e-05	0.00159	CbGpPWpGaD
Zolmitriptan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.27e-05	0.000402	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.26e-05	0.00158	CbGpPWpGaD
Zolmitriptan—Headache—Prednisolone—chronic obstructive pulmonary disease	5.24e-05	0.0004	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.23e-05	0.00157	CbGpPWpGaD
Zolmitriptan—Constipation—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000397	CcSEcCtD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.12e-05	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.05e-05	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.01e-05	0.00151	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.01e-05	0.00151	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000382	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000379	CcSEcCtD
Zolmitriptan—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.97e-05	0.000379	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.96e-05	0.00149	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.95e-05	0.00149	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.91e-05	0.00148	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.91e-05	0.00148	CbGpPWpGaD
Zolmitriptan—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000368	CcSEcCtD
Zolmitriptan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000367	CcSEcCtD
Zolmitriptan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000367	CcSEcCtD
Zolmitriptan—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.68e-05	0.00141	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.66e-05	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.63e-05	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.59e-05	0.00138	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	4.53e-05	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.5e-05	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.49e-05	0.00135	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000342	CcSEcCtD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.47e-05	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.44e-05	0.00134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.44e-05	0.00134	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.43e-05	0.00133	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.43e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.38e-05	0.00132	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.38e-05	0.00132	CbGpPWpGaD
Zolmitriptan—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000333	CcSEcCtD
Zolmitriptan—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.34e-05	0.00131	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.34e-05	0.00131	CbGpPWpGaD
Zolmitriptan—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.000328	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.29e-05	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.29e-05	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.25e-05	0.00128	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.24e-05	0.00128	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.24e-05	0.00128	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.21e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.18e-05	0.00126	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000317	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.02e-05	0.00121	CbGpPWpGaD
Zolmitriptan—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000307	CcSEcCtD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.98e-05	0.0012	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.9e-05	0.00118	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.9e-05	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.87e-05	0.00117	CbGpPWpGaD
Zolmitriptan—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000295	CcSEcCtD
Zolmitriptan—Rash—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000292	CcSEcCtD
Zolmitriptan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000292	CcSEcCtD
Zolmitriptan—Headache—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.000291	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.79e-05	0.00114	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.77e-05	0.00114	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.76e-05	0.00113	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.75e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.74e-05	0.00113	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.72e-05	0.00112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.72e-05	0.00112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.7e-05	0.00111	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.65e-05	0.0011	CbGpPWpGaD
Zolmitriptan—Nausea—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000276	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.56e-05	0.00107	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.52e-05	0.00106	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.48e-05	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.42e-05	0.00103	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.4e-05	0.00102	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.36e-05	0.00101	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.35e-05	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.34e-05	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.31e-05	0.000997	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.29e-05	0.000992	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.27e-05	0.000985	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.22e-05	0.000971	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.22e-05	0.000971	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.18e-05	0.000957	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.17e-05	0.000955	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.1e-05	0.000935	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.1e-05	0.000934	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.06e-05	0.000922	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.88e-05	0.000868	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.88e-05	0.000867	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.83e-05	0.000853	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.82e-05	0.000849	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.77e-05	0.000835	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.71e-05	0.000817	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.71e-05	0.000816	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.66e-05	0.000801	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.65e-05	0.000799	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.65e-05	0.000799	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.65e-05	0.000799	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000784	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.59e-05	0.000781	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.57e-05	0.000775	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.52e-05	0.000759	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.51e-05	0.000756	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.48e-05	0.000746	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-05	0.000745	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.45e-05	0.000737	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.43e-05	0.000731	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.39e-05	0.000721	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.38e-05	0.000716	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.36e-05	0.000712	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.25e-05	0.000678	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000672	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.2e-05	0.000664	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.17e-05	0.000655	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.16e-05	0.000651	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.15e-05	0.000647	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.11e-05	0.000636	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.08e-05	0.000626	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000619	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.02e-05	0.000609	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.02e-05	0.000609	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.98e-05	0.000597	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.94e-05	0.000585	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.93e-05	0.000582	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.92e-05	0.000578	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000557	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.85e-05	0.000557	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.84e-05	0.000555	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.8e-05	0.000543	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.72e-05	0.000517	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.72e-05	0.000517	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.7e-05	0.000512	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	0.00051	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.68e-05	0.000506	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.67e-05	0.000503	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.66e-05	0.000502	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.59e-05	0.000479	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.58e-05	0.000475	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.55e-05	0.000468	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.53e-05	0.000461	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.52e-05	0.000458	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.52e-05	0.000457	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.5e-05	0.000452	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.00045	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.49e-05	0.000448	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.48e-05	0.000445	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.45e-05	0.000436	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.38e-05	0.000416	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.37e-05	0.000414	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.36e-05	0.00041	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.35e-05	0.000407	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.33e-05	0.0004	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.3e-05	0.000392	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.000387	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.27e-05	0.000382	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000373	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.24e-05	0.000372	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.22e-05	0.000368	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.21e-05	0.000365	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.16e-05	0.00035	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000344	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.13e-05	0.000341	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.04e-05	0.000314	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.03e-05	0.00031	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.000306	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.95e-06	0.0003	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.91e-06	0.000299	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	9.72e-06	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.7e-06	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.57e-06	0.000288	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.49e-06	0.000286	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.39e-06	0.000283	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.26e-06	0.000279	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.22e-06	0.000278	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.13e-06	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.07e-06	0.000273	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.02e-06	0.000272	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.41e-06	0.000253	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.23e-06	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.21e-06	0.000247	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.04e-06	0.000242	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.88e-06	0.000237	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.81e-06	0.000235	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.65e-06	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.58e-06	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.43e-06	0.000224	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.27e-06	0.000219	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.23e-06	0.000218	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.21e-06	0.000217	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.91e-06	0.000208	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.67e-06	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.53e-06	0.000197	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.33e-06	0.000191	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.24e-06	0.000188	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.13e-06	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.12e-06	0.000184	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6e-06	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.99e-06	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.88e-06	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.82e-06	0.000175	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.81e-06	0.000175	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.54e-06	0.000167	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.51e-06	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.04e-06	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.98e-06	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.93e-06	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.61e-06	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.57e-06	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.52e-06	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.48e-06	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.76e-06	0.000113	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.75e-06	0.000113	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.58e-06	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.44e-06	0.000104	CbGpPWpGaD
